Tracking the SLS option chain helps you see every strike and expiry on SELLAS Life Sciences Group Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. SELLAS Life Sciences Group Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of SLS options activity at a glance. Use our scanner to monitor the SLS option chain in real time and filter for the SLS options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For SLS stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the SLS option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where SLS stock options are being actively traded and where they are not.
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. The company also develops nelipepimut-S, a cancer immunotherapy that targets human epidermal growth factor receptor 2, which is in Phase 2b clinical trials for the treatment of early-stage breast cancer.
It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors. The company was founded in 2012 and is headquartered in New York, New York.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls SELLAS Life Sciences Group Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen SLS options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of SLS stock options — let the full option chain come to you, pre-filtered and ready to trade.
